Subtype
Neuroblastic Tumor
CI-CAN-00001274Explore in graph →
137 active trials3 approved drugs28 evidence items
- NCIt
- C6963
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001274Explore in graph →
Clinical trials
619 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (80)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00309907 | Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant | completed | Phase 2 | 39 | Children's Oncology GroupNETWORK | 1 | Sep 29, 2017 | clinicaltrials |
| NCT00003513 | Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma | terminated | Phase 2 | 3 | Burzynski Research InstituteOTHER | 1 | Sep 28, 2017 | clinicaltrials |
| NCT02745756 | A Combined Cell Therapy Approach to the Treatment of Neuroblastoma | withdrawn | Phase 1 | 0 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 0 | Aug 30, 2017 | clinicaltrials |
| NCT03013387 | Dosimetry Guided PRRT With 90Y-DOTATOC | withdrawn | Phase 2 | 0 | Sue O'DorisioOTHER | 0 | Aug 25, 2017 | clinicaltrials |
| NCT00743496 | A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma | completed | Phase 1 | 50 | St. Jude Children's Research HospitalOTHER | 1 | Aug 17, 2017 | clinicaltrials |
| NCT00644696 | Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory Neuroblastoma | completed | Phase 1 | 18 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jul 6, 2017 | clinicaltrials |
| NCT00923650 | Informed Consent in Pediatric Cancer Trials | completed | — | 1 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT01130623 | A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT01132911 | A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and Lymphomas | completed | Phase 1 | 5 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT02439788 | 3RD GENERATION GD2 SPECIFIC CHIMERIC ANTIGEN RECEPTOR TRANSDUCED AUTOLOGOUS NATURAL KILLER T-CELLS FOR NEUROBLASTOMA(GINAKIT) | withdrawn | Phase 1 | 0 | Baylor College of MedicineOTHER | 1 | Jun 14, 2017 | clinicaltrials |
| NCT00808899 | Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma | terminated | Phase 2 | 4 | St. Jude Children's Research HospitalOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00795769 | Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant | completed | Phase 2 | 49 | Fred Hutchinson Cancer CenterOTHER | 1 | May 23, 2017 | clinicaltrials |
| NCT01288573 | A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone | completed | Phase 1 / Phase 2 | 46 | Genzyme, a Sanofi CompanyINDUSTRY | 12 | May 16, 2017 | clinicaltrials |
| NCT00324324 | Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant | terminated | Phase 3 | 240 | OHSU Knight Cancer InstituteOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT00900068 | Blood Samples From Patients on a Clinical Trial to CINV During HSCT | terminated | — | 9 | OHSU Knight Cancer InstituteOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT01241162 | Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma | completed | Phase 1 | 19 | University of LouisvilleOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT01308905 | Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET) | unknown | N/A | 50 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 6, 2017 | clinicaltrials |
| NCT01125800 | A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB | completed | Phase 1 / Phase 2 | 76 | Novartis PharmaceuticalsINDUSTRY | 6 | Mar 20, 2017 | clinicaltrials |
| NCT02919046 | Study Evaluating the Efficacy and Safety With CAR-T for Relapsed or Refractory Neuroblastoma in Children | unknown | N/A | 22 | Sinobioway Cell Therapy Co., Ltd.INDUSTRY | 1 | Mar 14, 2017 | clinicaltrials |
| NCT00003119 | Surgery in Treating Children With Neuroblastoma | completed | Phase 3 | 968 | Children's Oncology GroupNETWORK | 7 | Mar 13, 2017 | clinicaltrials |
| NCT00408681 | Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant(GVHD) | completed | N/A | 20 | Fred Hutchinson Cancer CenterOTHER | 1 | Mar 7, 2017 | clinicaltrials |
| NCT00947167 | A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors | terminated | Phase 2 | 4 | Pamela L. KunzOTHER | 1 | Mar 3, 2017 | clinicaltrials |
| NCT00582608 | Tumor Detection Using Iodine-131-Labeled Monoclonal Antibody 8H9 | terminated | N/A | 12 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 1, 2017 | clinicaltrials |
| NCT00445718 | Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging | completed | — | 97 | Children's Oncology GroupNETWORK | 3 | Feb 9, 2017 | clinicaltrials |
| NCT00726934 | The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients | completed | N/A | 149 | Indiana UniversityOTHER | 1 | Feb 8, 2017 | clinicaltrials |
| NCT03042429 | Combination Chemotherapy Followed by Stem Cell Transplant in High-risk Neuroblastoma Patients(NB2004-HR) | completed | Phase 3 | 360 | University of CologneOTHER | 1 | Feb 6, 2017 | clinicaltrials |
| NCT00946283 | Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome | terminated | N/A | 30 | Rutgers, The State University of New JerseyOTHER | 1 | Feb 3, 2017 | clinicaltrials |
| NCT01204450 | Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma | terminated | Phase 1 | 7 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Dec 23, 2016 | clinicaltrials |
| NCT00793351 | Reduced Intensity Stem Cell Transplantation in Children With Relapsed Neuroblastoma After Autologous Transplantation | completed | Phase 2 | 25 | Samsung Medical CenterOTHER | 1 | Oct 19, 2016 | clinicaltrials |
| NCT00960739 | Iodobenzylguanidine Meta-I131 and Topotecan in Young Patients With Refractory or Relapsed Metastatic Neuroblastoma(MIITOP) | completed | Phase 2 | 30 | Centre Oscar LambretOTHER | 1 | Aug 8, 2016 | clinicaltrials |
| NCT02457650 | T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies | unknown | Phase 1 | 36 | Shenzhen Second People's HospitalOTHER | 1 | Aug 3, 2016 | clinicaltrials |
| NCT01353300 | Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer | completed | — | 31 | Children's Oncology GroupNETWORK | 0 | Jul 11, 2016 | clinicaltrials |
| NCT01493830 | Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma | completed | — | 5 | Children's Oncology GroupNETWORK | 0 | Jul 11, 2016 | clinicaltrials |
| NCT00670410 | Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma | terminated | Phase 1 | 15 | Columbia UniversityOTHER | 1 | Jun 24, 2016 | clinicaltrials |
| NCT00049023 | Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors | completed | Phase 1 | 27 | O'Dorisio, M SOTHER | 1 | Jun 21, 2016 | clinicaltrials |
| NCT01048086 | 90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET) | withdrawn | Phase 2 | 0 | University of IowaOTHER | 1 | Jun 21, 2016 | clinicaltrials |
| NCT02615106 | Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma | unknown | Phase 2 | 60 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Jun 14, 2016 | clinicaltrials |
| NCT02771743 | Response-based Treatment of High-risk Neuroblastoma | unknown | Phase 2 | 54 | Samsung Medical CenterOTHER | 1 | May 24, 2016 | clinicaltrials |
| NCT01510600 | Studying Biomarkers in Samples From Patients With High-Risk Neuroblastoma | completed | — | 99 | Children's Oncology GroupNETWORK | 0 | May 19, 2016 | clinicaltrials |
| NCT00898391 | Study of DNA in Blood Samples From Patients With Neuroblastoma | completed | — | 329 | Children's Oncology GroupNETWORK | 1 | May 18, 2016 | clinicaltrials |
| NCT01169376 | Biomarkers in Young Patients With Neuroblastoma | completed | — | 380 | Children's Oncology GroupNETWORK | 0 | May 18, 2016 | clinicaltrials |
| NCT01387724 | Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma | completed | — | 300 | Children's Oncology GroupNETWORK | 0 | May 18, 2016 | clinicaltrials |
| NCT01553448 | Studying Gene Expression in Samples From Younger Patients With Neuroblastoma | completed | — | 75 | Children's Oncology GroupNETWORK | 0 | May 18, 2016 | clinicaltrials |
| NCT01589341 | Studying Chromosomes in Samples From Younger Patients With Neuroblastoma | completed | — | 300 | Children's Oncology GroupNETWORK | 1 | May 18, 2016 | clinicaltrials |
| NCT01407731 | Protein Expression in Human Neuroblastoma Tumor Samples | completed | — | 20 | Children's Oncology GroupNETWORK | 0 | May 17, 2016 | clinicaltrials |
| NCT01520233 | Gene Expression in Predicting Outcome in Samples From Patients With High-Risk Neuroblastoma | completed | — | 100 | Children's Oncology GroupNETWORK | 0 | May 17, 2016 | clinicaltrials |
| NCT01358604 | Biomarkers in Samples From Young Patients With Neuroblastoma | completed | — | 20 | Children's Oncology GroupNETWORK | 0 | Apr 15, 2016 | clinicaltrials |
| NCT00293384 | Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant | completed | N/A | 40 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Mar 15, 2016 | clinicaltrials |
| NCT01440283 | A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) in High Risk Abdominal Neuroblastoma | terminated | Phase 2 | 14 | St. Jude Children's Research HospitalOTHER | 1 | Mar 3, 2016 | clinicaltrials |
| NCT02444884 | MLN8237 to Treat Children With Relapsed/Refractory Solid Tumors | completed | Phase 1 | 54 | Children's Oncology GroupNETWORK | 0 | Feb 9, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Sep 29, 2017source: clinicaltrials